Filing Flows › Sutro Biopharma (STRO) › How it makes money
How Sutro Biopharma (STRO) makes money
Sutro Biopharma (STRO) made $9.8M of revenue in the second quarter 2026 (Q2 2026), -85% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $9.8M | 100.0% |
| Income tax | $1K | 0.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $9.8M | -85% |
| Q1 2026 | $14.5M | -16% |
| Q4 2025 | $11.6M | -21% |
| Q3 2025 | $9.7M | +14% |
| Q2 2025 | $63.7M | +148% |
| Q1 2025 | $17.4M | +34% |
| Q4 2024 | $14.8M | -87% |
From Sutro Biopharma's 10-Q filed Aug 12, 2026 (on EDGAR).
Questions
How does Sutro Biopharma make money?
Sutro Biopharma (STRO) made $9.8M of revenue in the second quarter 2026 (Q2 2026), -85% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.